Ott, C. J., Kopp, N., Bird, L., Paranal, R. M., Qi, J., Bowman, T., . . . Weinstock, D. M. (2012). BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia. Blood, 120(14), 2843. https://doi.org/10.1182/blood-2012-02-413021
Chicago-Zitierstil (17. Ausg.)Ott, Christopher J., et al. "BET Bromodomain Inhibition Targets Both C-Myc and IL7R in High-risk Acute Lymphoblastic Leukemia." Blood 120, no. 14 (2012): 2843. https://doi.org/10.1182/blood-2012-02-413021.
MLA-Zitierstil (9. Ausg.)Ott, Christopher J., et al. "BET Bromodomain Inhibition Targets Both C-Myc and IL7R in High-risk Acute Lymphoblastic Leukemia." Blood, vol. 120, no. 14, 2012, p. 2843, https://doi.org/10.1182/blood-2012-02-413021.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.